Martin W LaFleur

14PUBLICATIONS
82CO-AUTHORS
Molecular targetsCellular nervous systemMedical virologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 29, 2026
Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

|Aug 12, 2025
A STUB1-CHIC2 complex inhibits CD8<sup>+</sup> T cells to restrain tumor immunity.

Martin W LaFleur, Lauren E Milling, Priyamvada Prathima

|Oct 16, 2024
Neuropeptide signalling orchestrates T cell differentiation.

Yu Hou, Linyu Sun, Martin W LaFleur

|Oct 07, 2024
In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector Cells.

Martin W LaFleur, Jasmin M D'Andrea, Dillon G Patterson

|Sep 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control.

Sarah A Weiss, Amy Y Huang, Megan E Fung

|Feb 27, 2024
Framework for in vivo T cell screens.

Lauren E Milling, Samuel C Markson, Qin Tjokrosurjo

Pageof 3

Frequent Collaborators

8 joint publications

Arlene H Sharpe

7 joint publications

John G Doench

5 joint publications

W Nicholas Haining

4 joint publications

Marc A Schwartz